Ondine Biomed

Ondine Biomed (OBP)

Company name:Ondine Biomed
EPIC:OBP (delisted)Trading Currency:GBX
Market Sector:AIMISIN:CA68234M1068
Market Segment:AIMShare Type:DE
WWW Address:Description:COM SHS NPV
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 18.50 .advfn.com/imagesnew/2/gb/dot 0.0 [0.00] - - - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 23.46 126.80 - -23.58 - - - -

Ondine Biomed Key Figures

(at previous day's close)
Market Cap.23.46m
Shares In Issue126.80m
Prev. Close18.50
PE Ratio- 
Dividend Yield-%
EPS - basic-23.58p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-1.38p
Return On Equity (ROE)-1,166.53%
Operating Margin-%
PEG Factor- 
EPS Growth Rate-66,566.67%
Dividends PS Growth Rate-%
Net Debt0.88m
Gross Gearing88.98%
Quick Assets0.90m
Net Working Capital-0.30m
Intangibles / Fixed Assets45.79%
Turnover PS-p
Pre-Tax Profit PS-1.66p
Retained Profit PS-1.65p
Cash PS0.44p
Net Cash PS-0.62p
Net Tangible Asset Value PS *-0.07p
Net Asset Value PS0.14p
Spread- (-%) 

Ondine Biomed Balance Sheet

LSE:OBP:Liabilities+EQLSE:OBP:Assets

Share Price Performance

Sorry No Data Available

Share Price Chart (5 years)

Ondine Biomed Historic Returns

Sorry No Data Available

Ondine Biomed Key Management Ratios

Ondine Biomed Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 9.10 
Tobin's Q Ratio (excl. intangibles)11.35 
Dividend Yield-%
Market-to-Book Ratio130.87 
Price-to-Pre-Tax Profit PS-11.18 
Price-to-Retained Profit PS-11.22 
Price-to-Cash Flow PS-13.43 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS-281.97 
Price-to-Cash PS41.68 
Net Working Capital PS-0.24 
Price Pct to Working Capital PS-78.45%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Ondine Biomed Financial Ratios

(Leverage Ratios)
Debt Ratio34.63%
Debt-to-Equity Ratio0.53 
Debt-to-Equity Ratio (excl. Intgbl)-1.14 
Debt-to-Equity Market Value0.00 
Net Gearing54.39%
Net Gearing (excl. Intangibles)64.85%
Gross Gearing88.98%
Gross Gearing (excl. Intangibles)106.10%
Gearing Under 1 Year83.15%
Gearing Under 1 Year (excl. Intgbl)99.14%
Assets/Equity9.08 
Cash/Equity313.96 
(Liquidity Ratios)
Net Working Capital to Total Assets-18.38%
Current Ratio0.78 
Quick Ratio (Acid Test)0.67 
Liquidity Ratio0.42 
Cash & Equiv/Current Assets53.41%
(Solvency Ratios)
Enterprise Value22.99m
CFO/Sales- 
CFO/Attributable Profit- 
CFO/Assets-1.07 
CFO/Debt-1.21 
Total Debt/Equity Market Value0.06 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.69 
Total Debt1.45m
Total Debt/Net Current Assets-4.84%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-12.05%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs2 
Beta (60-Mnth)Beta (36-Mnth)
Sorry No Data AvailableSorry No Data Available

Ondine Biomed Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-765.35%
Return On Assets (ROA)-81.16%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-1,166.53%
Return On Investment (ROI)-236.59%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debtors-to-Sales-%
Debt Collection Period-Days

Ondine Biomed Dividends

Sorry No Data Available

Ondine Biomed Fundamentals

 31 Dec 2005 (CAD)31 Dec 2007 (CAD)31 Dec 2009 (CAD)31 Dec 2010 (CAD)
turnover--------m
pre tax profit-8.46--13.16--4.65--3.27-m
attributable profit-8.54--13.16--4.60--3.26-m
retained profit-8.54--13.16--4.60--3.26-m
eps - basic- -24.00 -0.06 -40.00 
eps - diluted- -24.00 -0.06 -40.00 
dividends per share- - - - 

Ondine Biomed Balance Sheet

 31 Dec 2005 (CAD)31 Dec 2007 (CAD)31 Dec 2009 (CAD)31 Dec 2010 (CAD)
LSE:OBP:Liabilities+EQLSE:OBP:AssetsLSE:OBP:Liabilities+EQLSE:OBP:AssetsLSE:OBP:Liabilities+EQLSE:OBP:AssetsLSE:OBP:Liabilities+EQLSE:OBP:Assets
 31 Dec 2005 (CAD)31 Dec 2007 (CAD)31 Dec 2009 (CAD)31 Dec 2010 (CAD)
ASSETS
fixed assets fixed assets0.100.57%0.997.63%0.4517.22%0.4819.10%m
intangibles intangibles0.030.17%0.110.88%0.6123.29%0.4116.13%m
fixed investments fixed investments0.432.50%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks0.120.72%0.574.39%0.217.85%0.239.19%m
debtors debtors1.086.26%1.189.07%0.3011.33%0.5320.99%m
cash & securities cash & securities15.4989.79%10.1578.03%1.0640.31%0.8834.59%m
TOTAL17.25100%13.00100%2.62100%2.53100%m
LIABILITIES
creditors - short creditors - short0.704.07%2.0115.49%1.2848.82%2.1183.15%m
creditors - long creditors - long0.040.25%0.151.12%--%--%m
creditors - other creditors - other--%--%0.062.39%0.155.84%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL0.754.32%2.1616.61%1.3451.21%2.2588.98%m
EQUITY
ord cap, reserves ord cap, reserves16.5095.68%10.8483.39%1.2848.79%0.2811.02%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL16.5095.68%10.8483.39%1.2848.79%0.2811.02%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Ondine Biomed Cash Flow Statement

31 Dec 2005 (CAD)31 Dec 2007 (CAD)31 Dec 2009 (CAD)31 Dec 2010 (CAD)
Operating CF-8.39-11.90-3.44-2.72m
Pre-Financing CF-9.64-11.92-1.74-2.24m
Retained CF1.7517.370.02-0.18m

Ondine Biomed Brokers

NameActivityTypeMnemonicCode
Canaccord Genuity LimitedMarket Maker(MMF)Broker/DealerCANAHOARGB21001
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V:gb D:20171121 06:36:13